Abstract-No large-scale, longitudinal studies have examined the combined effects of blood pressure (BP) and total cholesterol levels on long-term risks for subtypes of cardiovascular death in an Asian population. To investigate these relationships, a meta-analysis of individual participant data, which included 73 916 Japanese subjects (age, 57.7 years; men, 41.1%) from 11 cohorts, was conducted. During a mean follow-up of 15.0 years, deaths from coronary heart disease, ischemic stroke, and intraparenchymal hemorrhage occurred in 770, 724, and 345 cases, respectively. Cohortstratified Cox proportional hazard models were used. After stratifying the participants by 4 systolic BP ×4 total cholesterol categories, the group with systolic BP ≥160 mm Hg with total cholesterol ≥5.7 mmol/L had the greatest risk for coronary heart disease death (adjusted hazard ratio, 4.39; P<0.0001 versus group with systolic BP <120 mm Hg and total cholesterol <4.7 mmol/L). The adjusted hazard ratios of systolic BP (per 20 mm Hg) increased with increases in total cholesterol categories (hazard ratio, 1.52; P<0.0001 in group with total cholesterol ≥5.7 mmol/L). Similarly, the adjusted hazard ratios of total cholesterol increased with increases in systolic BP categories (P for interaction ≤0.04). Systolic BP was positively associated with ischemic stroke and intraparenchymal hemorrhage death, and total cholesterol was inversely associated with intraparenchymal hemorrhage, but no significant interactions between BP and total cholesterol were observed for stroke. High BP and high total cholesterol can synergistically increase the risk for coronary heart disease death but not for stroke in the Asian population. (Hypertension. 2015;65:517-524.
P revious cohort studies in Western countries demonstrated that high total cholesterol levels strengthened the association between high blood pressure (BP) and the risk for death from coronary heart disease (CHD). [1] [2] [3] However, the research group of the Asia Pacific Cohort Studies Collaboration (APCSC) reported that the positive associations of BP with the risk for CHD was weaker in the group with higher cholesterol levels than in those with lower cholesterol levels. 4 Asians, 4 ethnic heterogeneity could have contributed to the inconsistent results of the combined effects of BP and total cholesterol. Although the Suita study reported the combined effect of total cholesterol and BP levels on the risk for CHD in a Japanese population, the relatively small sample size and the small number of events limit the interpretation of the results. 5 Asian populations have a higher incidence of stroke and a lower incidence of CHD than Western populations. 6 Although it is well reported that high BP is a strong risk factor for ischemic stroke or intraparenchymal hemorrhage, 4, 5, 7 there remains debate about the inverse association between total cholesterol and an increased risk for intraparenchymal hemorrhage, which was mainly reported by Japanese cohorts. [8] [9] [10] [11] [12] [13] [14] Furthermore, there is limited information on the combined effect of BP and total cholesterol levels on the risk for subtypes of stroke, especially for intraparenchymal hemorrhage. 4, 5 Although these issues remain unsolved, there has been no large-scale, longitudinal study examining the combined effects of BP and total cholesterol levels on the risk for subtypes of cardiovascular disease (CVD) in an exclusively Asian population. The objective of the present study was to examine these points by conducting a meta-analysis of the individual participant data (meta-analysis), which included Japanese cohorts enrolled in the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN).
Methods

Study Populations
The construction of the EPOCH-JAPAN database has been described previously. 15 Figure S1 in the online-only Data Supplement shows cohort and participant selection. Finally, 73 916 participants from 11 cohorts (Ohsaki, Ohasama, Oyabe, YKK workers, Suita, RERF cohort, Hisayama, JACC, NIPPON DATA 80, NIPPON DATA 90, and Osaka; Table S1 ) were included the present analyses. The details are provided in the online-only Data Supplement.
Data Collection and Outcomes
BP was measured using a mercury sphygmomanometer when each participant was in a seated position, except for the Ohasama study 16 in which an automated device was used. Serum total cholesterol levels were measured enzymatically in all cohorts, with the exception of the NIPPON DATA80 cohort. 17 The underlying causes of death were coded according to the Ninth International Classification of Disease (ICD-9) to the end of 1994 and the 10th International Classification of Disease (ICD-10) from the beginning of 1995.
The details are provided in the online-only Data Supplement.
Statistical Analysis
The participants were classified into 4 categories according to their systolic BP levels (120, 120-139, 140-159, and ≥160 mm Hg) and further classified into 4 groups according to their total cholesterol levels (<4.7, 4.7-5.1, 5.2-5.6, and ≥5.7 mmol/L). Multivariable adjusted hazard ratios for death from CHD, ischemic stroke, intraparenchymal hemorrhage, or total CVD in each systolic BP-total cholesterol category were estimated. Then, cohort-stratified Cox proportional hazard models, which accounted for the variability of baseline hazards among cohorts, with reference to the group with systolic BP <120 mm Hg with total cholesterol <4.7 mmol/L, were used. Covariates included in the model were sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. The adjusted hazard ratios per 1 SD increase in systolic BP or total cholesterol after stratifying the participants according to the total cholesterol categories and the systolic BP categories, respectively, were also calculated. The details are provided in the online-only Data Supplement. Table 1 shows the baseline characteristics according to the combination of 4 systolic BP categories and 4 total cholesterol categories. Significant differences among the groups were observed in all characteristics (P<0.0001). During a mean follow-up of 15.0 years (median [25th-75th percentiles], 15.0 [12.7-19.3] ; maximum: 24.0 years), deaths from total CVD occurred in 3696 participants. Total CVD deaths were because of CHD in 770 and total stroke in 1587 (ischemic stroke in 724 and intraparenchymal hemorrhage in 345). Table 2 shows the numbers of deaths and the sex-and age-adjusted death rates per 1000 person-year in each group. Figure (A) indicates the adjusted hazard ratios for deaths from CHD in each group (the corresponding 95% confidence intervals are shown in Table S2 ). Among the 16 groups, the group with systolic BP ≥160 mm Hg with total cholesterol ≥5.7 mmol/L had the greatest risk for CHD death (adjusted hazard ratio [95% confidence interval], 4.39 [2.68-7.18 ]; P<0.0001 versus group with systolic BP <120 mm Hg and total cholesterol <4.7 mmol/L; Figure [A] ). In relation to the risk for stroke death, stepwise relationships were observed between systolic BP and the risk for ischemic stroke death and intraparenchymal hemorrhage death, whereas total cholesterol was inversely associated with the risk for intraparenchymal hemorrhage death (Figure [B] and [C] ). The greatest risk for total CVD death was observed in the group with systolic BP ≥160 mm Hg with total cholesterol ≥5.7 mmol/L (Figure [D] ). When all of the analyses were repeated using diastolic BP instead of systolic BP, similar results were obtained (Table S3) .
Results
Each 1 SD increase in systolic BP (20.0 mm Hg) was significantly associated with an increased risk for CHD death Table 3 ). The adjusted hazard ratio of systolic BP for CHD death increased gradually with increases in total cholesterol categories (P for interaction=0.04; Table 3 ). Similarly, each 1 SD increase in total cholesterol levels (=1.0 mmol/L) was significantly associated with CHD death, and the adjusted hazard ratio increased with increases in systolic BP categories (P for interaction=0.0006; Table 4 ). A higher systolic BP was significantly associated with an increased risk for ischemic stroke death or intraparenchymal hemorrhage death, whereas total cholesterol was inversely associated with intraparenchymal hemorrhage death. There were no significant interactions between systolic BP and total cholesterol levels on the risk for ischemic stroke death or intraparenchymal hemorrhage death (P for interaction ≥0.09; Tables 3 and 4) . Total cholesterol levels were inversely associated with total CVD in the group with systolic BP <120 mm Hg, but they were positively associated with total CVD in the group with systolic BP ≥160 mm Hg (P for interaction=0.0006; Table 4 ). Similar results were obtained after excluding the first 3 years (Table S4 ). There were no significant interactions between sex (men/women), as well as age (<65/≥65 years), and the 16 categories on the risk for CHD death (Table S5) , ischemic stroke death (Table S6) , and intraparenchymal hemorrhage death (Table S7 ; P for interaction ≥0.06). The association between higher systolic BP and higher total cholesterol and the risk for total CVD death was marked in participants aged <65 years and men (P for interaction ≤0.03; Table S8 ), but it was weak in participants aged ≥65 or ≥75 years and in women (Tables S8 and S9 ). There were no significant interactions when stratified analyses according to the use of antihypertensive agents were done among participants with information on antihypertensive treatments (n=37 326; P for interaction ≥0.09). After including 5407 individuals without history of CVD and without data on body mass index or smoking or drinking status, similar results were observed (Table  S10) . Table S11 shows the results when including systolic BP and total cholesterol in the same model.
In the analyses of Tables 3 and 4 , the highest heterogeneity was observed in the analysis of the association between total cholesterol and the risk for total CVD death (I 2 =61.6; P=0.007), whereas heterogeneity across cohorts was low or modest for most analyses (0≤I 2 ≤58.5%; P≥0.01).
Discussion
This is one of the largest epidemiological studies with long follow-up demonstrating the risks for subtypes of cardiovascular death according to BP and total cholesterol levels in an Asian population.
The positive association between BP and the risk for CHD death was greater in individuals with higher total cholesterol levels than in those with lower levels in the present study. The association between total cholesterol and the risk for CHD death was clearer in the group with higher systolic BP. The previous studies in 19 189 3 Although similar tendencies were observed in the APCSC study, they reported that the association of systolic BP with the risk for CHD death was steeper in individuals with lower cholesterol levels than in those with higher levels, in contrast to the present findings. 4 The variation in results between the APCSC study and the present study might be partly caused by the differences in mean follow-up duration (6.7 versus 15.0 years) or ethnic heterogeneity (population from Asian and Australasian regions versus only a Japanese population). 4 The impact of metabolic syndrome factors on the Adjusted hazard ratios for death from (A) coronary heart disease (CHD), (B) ischemic stroke, (C) intraparenchymal hemorrhage, and (D) total cardiovascular disease (CVD) in each group according to the levels of systolic blood pressure (BP) and total cholesterol were calculated using cohort-stratified Cox proportional hazards models. All analyses were stratified by cohort. The analyses included 73 916 Japanese people from 11 cohorts. Covariates were sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. *P<0.05, †P<0.0001 vs group with systolic BP <120 mm Hg with total cholesterol <4.7 mmol/L. Hazard ratios were adjusted for sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. All analyses were stratified by cohort. The analyses included 73 916 Japanese from 11 cohorts. One SD of systolic BP is 20.0 mm Hg. BP indicates blood pressure; CHD, coronary heart disease; CVD, cardiovascular disease. *P<0.0001 and †P<0.05.
risk of CVD has been reported to differ between the population in the United States and that in Japan. 18 The present findings suggest that, in the Asian population, high BP and high total cholesterol levels may synergistically interact to increase the risk of CHD death. This may partly support the responseto-injury hypothesis 19 or the inflammation hypothesis, 20 that is, both vascular injury by hypertension and lipid deposition may be necessary for CHD.
There was no significant synergistic effect of systolic BP and total cholesterol levels on the risk for ischemic stroke death. Similar to the results of the previous study, 21 no significant association between total cholesterol and the risk of ischemic stroke death was observed. However, the mechanisms related to the risk for cardioembolic infarction are thought to differ from those for atherothrombotic infarction, 12, 22 and cardioembolic infarctions are more common in Japanese than Western populations. 12 Therefore, the same conclusion may not apply to the risk of atherothrombotic infarction death.
Similar to the present finding, the inverse association between total cholesterol and intraparenchymal hemorrhage death was also reported by previous studies in Japanese populations [8] [9] [10] [11] [12] or non-Japanese 13, 14 or and by a recent metaanalysis based on 19 European or Asian cohorts. 23 The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, which had stroke as the primary end point, demonstrated that hemorrhage was more frequent in patients treated with statins, especially in those with a history of hemorrhage or hypertension. 24 There are several hypotheses for this issue, 25 which has been raised in a National Heart, Lung, and Blood Institute Conference. 26 First, low total cholesterol levels may reflect malnutrition or poor general condition, which relates to death after onset, not to onset per se, because a clear association between low cholesterol and hemorrhage tends to be observed in epidemiological studies having mortality as an end point. 9, 13, 14, 27, 28 Second, some remaining confounding factors such as socioeconomic status, nutrient balance, or excess alcohol intake might exist. These hypotheses suggest that low total cholesterol itself may not cause hemorrhage. Further studies taking into account nonfatal events and residual confounding factors are needed to examine these possibilities. The third hypothesis is that low total cholesterol may induce angionecrosis, especially with the coexistence of hypertension. However, this was not proven by the present study because there was no significant interaction between BP and total cholesterol on the risk for intraparenchymal hemorrhage stoke death (Tables 3 and 4 ). This result is similar to previous findings of the Ibaraki Prefectural Health Study. 9 In relation to the risk for total CVD, the combined effect of systolic BP and total cholesterol level was remarkable among men or participants aged <65 years in the present study (Tables S8 and S9 ). Similar tendencies have been reported by the APCSC and the French study. 2, 4 Therefore, the present findings suggest that, also in Asian populations, the impact of the joint effect of BP and total cholesterol on the risk for total CVD would be greater in men or in a younger population.
The present findings must be interpreted within the context of their potential limitations. First, the use of cholesterollowering therapy, including statins, was not taken into account because the information on cholesterol-lowering therapy was available in only 10 153 participants (13.7%). However, baseline surveys in 11 cohorts of EPOCH-JAPAN were mostly performed before 1989, which is when statin use started in Japan. Therefore, it is less likely that the use of statins at baseline affected the present findings. Second, BP and total cholesterol levels were measured at the beginning of the follow-up period, and regression dilution bias was not taken into account. 29 Participants might have been reclassified if they had been examined during the follow-up period. Third, we excluded several cohorts without data on CVD outcomes or on history of CVD. Furthermore, the methods of BP measurement and ascertainment of events were not identical among cohorts. This was taken into account by considering the cohort as strata in the Cox proportional hazard models. 30 However, the interactions between BP and total cholesterol on the risk for death from CVD or its subtypes might partly be affected by the heterogeneity in the cohorts' characteristics. Fourth, the present study predominantly included a middle-aged and older Asian population. This limits the generalizability of our findings. Fifth, we did not consider the low-or high-density lipoprotein and triglyceride levels. These lipids have different effects on the prothrombotic tendency, atherosclerosis, or CVD. Further studies considering the detailed lipid status are 
Perspective
People with higher BP and higher total cholesterol levels had the greatest risk for CHD death. Furthermore, there was a synergistic interaction between higher BP and higher total cholesterol levels for the risk for CHD death but not for stroke. These results suggest that poor lipid management may increase the adverse effect of high BP on CHD risk and vice versa in the Asian population. What Is New?
• We have conducted the participant-level meta-analysis including 73 916
Japanese from 11 cohorts with a mean of 15.0 years follow-up. Individuals with systolic blood pressure ≥160 mm Hg with total cholesterol ≥5.7 mmol/L had the greatest risk for coronary heart disease death (hazard ratio, 4.39; 95% confidence intervals, 2.68-7.18) compared with those with systolic blood pressure <120 mm Hg with total cholesterol <4.7 mmol/L.
What Is Relevant?
• There was a significant interaction between higher blood pressure and higher total cholesterol levels for the risk of coronary heart disease death (interaction P≤0.04).
• The interaction between blood pressure and total cholesterol level was not significant for ischemic stroke death or intraparenchymal hemorrhage death (interaction P≥0.09).
• Total cholesterol levels were inversely associated with total cardiovascular death in the group with systolic blood pressure <120 mm Hg, but positively associated in the group with systolic blood pressure ≥160 mm Hg (interaction P=0.0006).
Summary
We demonstrated that the positive association between blood pressure and the risk of coronary heart disease death was remarkably observed in participants with higher total cholesterol levels. High blood pressure and high total cholesterol can synergistically increase the risk for coronary heart disease death. These findings suggest that poor lipid management may enhance the adverse effect of high blood pressure on coronary heart disease risk and vice versa in the Asian population. 
Methods
Study Populations
The construction of the EPOCH-JAPAN database has been described previously. 1 The inclusion criteria for the EPOCH-JAPAN project were as follows: collection of BP, anthropometric indices, and health examination measures; follow-up period >5 years and >1000 participants in principle; and nationwide, as well as regional, Japanese cohort study. All studies contributing to the EPOCH-JAPAN project received ethical approval and have been described in detail in peer-reviewed publications. Figure S1 shows the selection of cohorts and participants. At the time of writing this report, the EPOCH-JAPAN database included 12 eligible cohorts with data on CVD outcomes. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Of the total 101250 participants, 90438, aged 40 to 90 years with data on the cause of death, were included. Finally, 73916 participants from 11 cohorts were analyzed. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] All participants gave their informed consent. The characteristics of each cohort are shown in Table S1 .
Data Collection
Blood pressure was measured using a mercury sphygmomanometer when each participant was in a seated position, except for the Ohasama study 3 in which an automated device was used. Participants rested before measurement except in the Ohsaki study. Serum total cholesterol levels were measured enzymatically in all cohorts, with the exception of the NIPPON DATA80 cohort 10 , in which total cholesterol was measured by the Lieberman-Burchard direct method. In all cohorts, a questionnaire was used to obtain detailed information on each participant's medical history, intake of medications, and drinking and smoking habits.
Outcomes
In accordance with the Family Registration Law in Japan, all death certificates are forwarded to the Ministry of Health, Labour and Welfare via the public health center in the area of residence. 14 Registration of death is required by law and believed to be complete. Other sources used in some studies included autopsy reports 6, 8 , medical records 3, 6, 8 , health examinations 
Statistical Analysis
In accordance with the current hypertension guidelines 15, 16 , the participants were classified into 4 categories according to their systolic (diastolic) BP levels: To analyze the relationship between the 16 groups and participants' characteristics, means and proportions were compared using analysis of variance (ANOVA) and the χ 2 test for univariate analysis. Death rates were calculated stratified by the 16 groups according to systolic BP and total cholesterol levels while standardizing rates for sex and age (<50, 50-64, and ≥65 years) by the direct method. Multivariable adjusted hazard ratios for death from CHD, ischemic stroke, intraparenchymal hemorrhage, or total CVD in each systolic BP-total cholesterol category were also estimated. Then, cohort-stratified Cox proportional hazard models, which accounted for the variability of baseline hazards among cohorts, with reference to the group with systolic BP <120 mmHg with total cholesterol <4.7 mmol/L, were used. Covariates included in the model were sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. The adjusted hazard ratios per 1 standard deviation (SD) increase in systolic BP or total cholesterol after stratifying the participants according to the total cholesterol categories and the systolic BP categories, respectively, were also calculated.
Interactions were assessed by adding an interaction term to the Cox model. Heterogeneity in the hazard ratios among the 11 cohorts was assessed by the I 2 statistic. Statistical significance was an α-level of less than 0.05 on two-sided tests.
SAS software, version 9.3 (SAS Institute, Cary, NC) was used in the present study. 41) † Hazard ratios were adjusted for sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. All analyses were stratified by cohort. The analyses included 73916 Japanese from 11 cohorts.
The numbers of death were 770 for CHD, 724 for ischemic stroke, 345 for intraparenchymal hemorrhage, and CVD for 3696. BP, blood pressure. CHD, coronary heart disease. CVD, cardiovascular disease. *P<0.05, †P<.0001. ratios were adjusted for sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. All analyses were stratified by cohort. The analyses included 73916 Japanese from 11 cohorts. The numbers of death were 770 for CHD, 724 for ischemic stroke, 345 for intraparenchymal hemorrhage, and CVD for 3696. BP, blood pressure. CHD, coronary heart disease. CVD, cardiovascular disease. *P<0.05, †P<.0001. 38) † Hazard ratios were adjusted for sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. All analyses were stratified by cohort. The analyses included 73916 Japanese from 11 cohorts. After censoring of the first 3 Years, the numbers of death were 705 for CHD, 674 for ischemic stroke, 301 for intraparenchymal hemorrhage, and 3372 for CVD. BP, blood pressure. CHD, coronary heart disease. CVD, cardiovascular disease. *P<0.05, †P<.0001. 1.27 (0.85-1.90) Hazard ratios were adjusted for sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. All analyses were stratified by cohort. The analyses included 4435 Japanese aged ≥75 years from 11 cohorts. The numbers of deaths were 182 for CHD, 229 for ischemic stroke, 67 for intraparenchymal hemorrhage, and 967 for CVD. BP, blood pressure. CHD, coronary heart disease. CVD, cardiovascular disease. NA, not applicable. *P<0.05. Japanese include 5407 without a history of CVD and without data on covariates and were from 11 cohorts. Hazard ratios were adjusted for sex, age, body mass index, former smoking, current smoking, former drinking, current drinking, and each missing value (missing = 1, present = 0) for smoking/drinking status. Missing body mass index values were interpolated from the regression slope on age by sex. All analyses were stratified by cohort. The numbers of deaths were 830 for CHD, 767 for ischemic stroke, 371 for intraparenchymal hemorrhage, and 3996 for CVD. BP, blood pressure. CHD, coronary heart disease. CVD, cardiovascular disease. *P<0.05. 
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Systolic BP and total cholesterol were included in the same model. Hazard ratios were adjusted for sex, age, body mass index, former smoking, current smoking, former drinking, and current drinking. The analyses included 73916
Japanese from 11 cohorts. The numbers of deaths were 770 for CHD, 724 for ischemic stroke, 345 for intraparenchymal hemorrhage, and 3696 for CVD. BP, blood pressure. CHD, coronary heart disease. CVD, cardiovascular disease. Figure S1 .
Flow diagram of study population. BP, blood pressure. CVD, cardiovascular disease.
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